Ken Griffin T Rx Ade Health, Inc Transaction History

Citadel Advisors LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$1.24 - $2.47 $6,185 - $12,320	-4,988 Reduced 27.43%	13,195 $20,000
Q1 2022 May 16, 2022	SELL	$1.76 - $2.77 $13,328 - $20,977	-7,573 Reduced 29.4%	18,183 $50,000
Q4 2021 Feb 14, 2022	BUY	$2.36 - $4.94 $60,784 - $127,234	25,756 New	25,756 $60,000
Q1 2021 May 17, 2021	SELL	$5.21 - $7.85 $66,167 - $99,695	-12,700 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$4.1 - $6.54 $52,069 - $83,058	12,700 New	12,700 $67,000

Ticker MEDS
Exchange NASDAQ
Sector Healthcare
Industry Pharmaceutical Retailers
Shares Outstandng 9,318,710
Market Cap $68.5M
Description
TRxADE HEALTH, Inc. operates as a health services IT company in the United States. The company focuses on digitalizing the retail pharmacy experience by optimizing drug procurement, prescription journey, and patient engagement. It operates the TRxADE drug procurement marketplace, which fosters price transparency and serves approximately 11,800 m...

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.